Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rob Lambkin-Williams (Brighton, United Kingdom), Daniel Fullen, Bryan Murray, Ganesh Balaratnam, Julie Mori, Andrew Catchpole, Anthony Gilbert, Fiona Hughes, Rob Lambkin-Williams. LATE-BREAKING ABSTRACT: Discovering new treatments for asthma and COPD. The use of the human viral challenge model with a newly manufactured and characterised GMP human rhinovirus. Eur Respir J 2015; 46: Suppl. 59, 638

Member's Comments

No comment yet.

Related content which might interest you: Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Spectrum of viral pathogens in adults patients with infectious exacerbations of bronchial asthma Source: Annual Congress 2013 –Viral infections Year: 2013 Prevalence of respiratory virus in a selected population of children with asthma exacerbation Source: Annual Congress 2013 –Preschool wheeze Year: 2013 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Human rhinovirus (HRV) induced changes in mild asthma: Time course of clinical and inflammatory biomarker changes Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Identification of viral species in asthma patients with and without aspirin hypersensitivity Source: Annual Congress 2013 –Viral infections Year: 2013 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model) Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 COVID-19: Potential impact on asthma patients Source: ERS Webinar 2020: COVID-19: Potential impact on asthma patients Year: 2020 The efficacy of multiple use of interferon-gamma inducer in treatment of recurrent acute respiratory viral infections in children with bronchial asthma Source: Annual Congress 2013 –Preschool wheeze Year: 2013 LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Role of the acetylcholine in the virus-induced bronchoconstriction Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016